Pretreatment prognostic nutritional index as a novel biomarker in non-small cell lung cancer patients treated with immun…
この記事を読む
「論文メモ」の記事一覧 28ページ
この記事を読む
TKIと殺細胞性抗がん剤併用の再現性
Gefitinib Versus Gefitinib Plus Pemetrexed and Carboplatin Chemotherapy in EGFR-Mutated Lung Cancer. Noronha V et al. J …
この記事を読む
免疫療法単剤、腫瘍マーカー低下も早期効果指標となる
Early serum tumor marker dynamics predict progression-free and overall survival in single PD-1/PD-L1 inhibitor treated a…
この記事を読む
維持療法に適しているのはベバシズマブ、ペメトレキセド、それとも両者？
Pemetrexed, Bevacizumab, or the Combination As Maintenance Therapy for Advanced Nonsquamous Non-Small-Cell Lung Cancer: …
この記事を読む
ADAと免疫療法
Correlation between serum adenosine deaminase activity and efficacy of anti-programmed cell death-1 antibody. Saiki M et…
この記事を読む
HPDは疲弊T細胞と関連する
Hyperprogressive disease during PD-1/PD-L1 blockade in patients with non-small-cell lung cancer. Kim CG, Ann Oncol. 2019…
この記事を読む
輸血の既往が予後を変える？
Prognostic impact of blood transfusion in patients with metastatic non-small cell lung cancer receiving chemotherapy. Sa…
この記事を読む
アファチニブのlast resort
First-line afatinib for advanced EGFRm+ NSCLC: Analysis of long-term responders in the LUX-Lung 3, 6, and 7 trials. Schu…
この記事を読む
ICIにおける脳転移の予後
Outcome of Patients with Non-Small Cell Lung Cancer and Brain Metastases Treated with Checkpoint Inhibitors. Hendriks LE…
この記事を読む
EGFR-TKIへの耐性機序としてのBRAF rearrangements
Acquired BRAF Rearrangements Induce Secondary Resistance to EGFR therapy in EGFR-Mutated Lung Cancers. Vojnic M et al. J…